|
Vaccine Detail
S. pneumoniae PhpA-79 Protein Vaccine |
Vaccine Information |
- Vaccine Name: S. pneumoniae PhpA-79 Protein Vaccine
- Target Pathogen: Streptococcus pneumoniae
- Target Disease: Pneumonia
- Vaccine Ontology ID: VO_0004063
- Type: Subunit vaccine
- Status: Research
- Antigen: Recombinant PhpA-79
- phpA
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Adjuvant:
- Adjuvant name:
- VO adjuvant ID: VO_0001250
- Description: 100 μg of monophosphoryl lipid A (MPL; Corixa, Hamilton, Mont.) per dose (Zhang et al., 2001).
- Immunization Route: subcutaneous injection
|
Host Response |
Mouse Response
- Host Strain: CBA/N
- Vaccination Protocol: CBA/N mice, at 10 animals per group, were immunized with 5 μg of either rPhpA-79 or rPhpA-20. For parenteral immunization, rPhpA-79 or rPhpA-20 protein was mixed with 100 μg of monophosphoryl lipid A (MPL; Corixa, Hamilton, Mont.) per dose to a final volume of 200 μl in saline and then injected s.c. into mice. All groups received a booster with the same dose and by the same route 3 and 5 weeks after the primary immunization. Control mice were injected with MPL alone (Zhang et al., 2001).
- Challenge Protocol: Mice were challenged with either serotype 3 or serotype 14 streptomycin-resistant S. pneumoniae (Zhang et al., 2001).
- Efficacy: Immunization with either rPhpA-79–MPL provided 100% protection against death caused by type 3 S. pneumoniae infection (Zhang et al., 2001).
|
References |
Zhang et al., 2001: Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK, Green BA. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infection and immunity. 2001; 69(6); 3827-3836. [PubMed: 11349048].
|
|